IVOCT Has a Bright Future in the Identification of Vulnerable Plaques

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1529-1531. doi: 10.1016/j.jcmg.2018.10.008. Epub 2018 Nov 28.

Authors

Marc D Feldman¹, Andrew G Cabe², Thomas E Milner³

Affiliations

¹ Department of Cardiology, University of Texas Health and Science Center at San Antonio, University of Texas Health San Antonio, San Antonio, Texas. Electronic address: feldmanm@uthscsa.edu.
² Department of Cardiology, University of Texas Health and Science Center at San Antonio, University of Texas Health San Antonio, San Antonio, Texas.
³ Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas.

PMID: 30503625
DOI: 10.1016/j.jcmg.2018.10.008

No abstract available

Keywords: atherosclerosis; myocardial infarction; optical coherence tomography; statin.

Publication types

Editorial
Comment

MeSH terms

Coronary Vessels
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Myocardial Infarction*
Plaque, Atherosclerotic*
Tomography, Optical Coherence

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors